Complete Response to Dual Immunotherapy in a Young Adult with Metastatic Alveolar Soft Part Sarcoma Enabled by a Drug Recovery Program in a Community Practice

Keyphrases

• Older Adults 100%
• Complete Response 100%
• Community Practice 100%
• Alveolar Soft Part Sarcoma 100%
• Recovery Program 100%
• Drug Recovery 100%
• Dual Immunotherapy 100%
• Local Control 66%
• Lung 33%
• United States 33%
• Soft Tissue 33%
• Standardized Uptake Value 33%
• Therapeutic Potential 33%
• Metastatic Disease 33%
• Relapsed Disease 33%
• Appropriate Therapy 33%
• Young Population 33%
• Disease-free 33%
• Insurance 33%
• Community Setting 33%
• Lack of Access 33%
• Rare Tumors 33%
• Ipilimumab 33%
• Nivolumab 33%
• 4-cycle 33%
• Coordinated Care 33%
• Primary Mass 33%
• Underinsured 33%
• Response to Immunotherapy 33%
• Inguinal Lymph Node 33%
• Immunotherapy Agents 33%
• Single Mothers 33%
• Barriers to Cancer Care 33%
• Access to Therapy 33%
• Thigh Mass 33%
• Older Unemployed 33%

Medicine and Dentistry

• Immunotherapy 100%
• Alveolar Soft Part Sarcoma 100%
• Drug Substitution 60%
• Adolescence 60%
• Diseases 40%
• Biological Marker 20%
• Malignant Neoplasm 20%
• Metastatic Carcinoma 20%
• Standardized Uptake Value 20%
• Rare Tumor 20%
• Ipilimumab 20%
• Nivolumab 20%
• Care Coordination 20%
• Inguinal Lymph Node 20%
• Lung 20%
• Thigh 20%